Traws Pharma
Stock Forecast, Prediction & Price Target
Traws Pharma Financial Estimates
Traws Pharma Revenue Estimates
Traws Pharma EBITDA Estimates
Traws Pharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $226K N/A | $226K 0% | $226K 0% | Avg: $300K Low: $300K High: $300K avg. 32.74% | Avg: $300K Low: $300K High: $300K avg. 0% | Avg: $300K Low: $300K High: $300K avg. 0% | Avg: $400K Low: $400K High: $400K avg. 33.33% |
Net Income
% change YoY
| $-16.16M N/A | $-18.96M -17.32% | $-18.94M 0.08% | Avg: $-17.42M Low: $-17.42M High: $-17.42M avg. 8.06% | Avg: $-17.00M Low: $-17.00M High: $-17.00M avg. 2.40% | Avg: $-19.93M Low: $-19.93M High: $-19.93M avg. -17.28% | Avg: $-24.34M Low: $-24.34M High: $-24.34M avg. -22.10% |
EBITDA
% change YoY
| $-16.80M N/A | $-19.61M -16.72% | $-20.28M -3.41% | Avg: $-300K Low: $-300K High: $-300K avg. 98.52% | Avg: $-300K Low: $-300K High: $-300K avg. 0% | Avg: $-300K Low: $-300K High: $-300K avg. 0% | Avg: $-400K Low: $-400K High: $-400K avg. -33.33% |
EPS
% change YoY
| -$0.96 N/A | -$0.91 5.20% | -$0.9 1.09% | Avg: -$0.83 Low: -$0.83 High: -$0.83 avg. 7.77% | Avg: -$0.81 Low: -$0.81 High: -$0.81 avg. 2.40% | Avg: -$0.95 Low: -$0.95 High: -$0.95 avg. -17.28% | Avg: -$1.16 Low: -$1.16 High: -$1.16 avg. -22.10% |
Operating Expenses
% change YoY
| $16.72M N/A | $19.85M 18.72% | $20.50M 3.29% | Avg: $9.55M Low: $9.55M High: $9.55M avg. -53.42% | Avg: $9.55M Low: $9.55M High: $9.55M avg. 0% | Avg: $9.55M Low: $9.55M High: $9.55M avg. 0% | Avg: $12.73M Low: $12.73M High: $12.73M avg. 33.33% |
FAQ
What is Traws Pharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -7.22% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -17.42M, average is -17.42M and high is -17.42M.
What is Traws Pharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 16.51% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $300K, average is $300K and high is $300K.
What is Traws Pharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -7.30% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.83, average is -$0.83 and high is $-0.83.